endocrine Flashcards
(40 cards)
aspart insulin
rapid acting
best for post-meal hypergylcemia
lispro insulin
rapid acting
best for post-meal hypergylcemia
Glulisine
rapid acting
best for post-meal hypergylcemia
regular insulin
short acting
best for iv use
NPH
intermediate acting
twice daily
Glargine
long-acting
once daily
Dtermir
Long-acting
once daily
metformin
biguanides: decrease gluconeo,increase glycosis, increase glu uptake
use in 1st line type 2
tos: Gi upset, lactic acidosis(CI in renal failure)
Tolbutamide
1st Generation, sulfonylureas
Close K channel in beta-cell membrane, so cell depolarizes->Ca influx–>trigger of insulin release
tox: disulfiram like side effect
Chlorpropamide
1st Generation, sulfonylureas
Close K channel in beta-cell membrane, so cell depolarizes->Ca influx–>trigger of insulin release
tox: disulfiram like side effect
Glyburide
2nd Generation, sulfonylureas
Close K channel in beta-cell membrane, so cell depolarizes->Ca influx–>trigger of insulin release
tox: hypoglycemia
Glimepiride
2nd Generation, sulfonylureas
Close K channel in beta-cell membrane, so cell depolarizes->Ca influx–>trigger of insulin release
tox: hypoglycemia
Glipizide
2nd Generation, sulfonylureas
Close K channel in beta-cell membrane, so cell depolarizes->Ca influx–>trigger of insulin release
tox: hypoglycemia
Pioglitazone
Glitazones/thiazolidinediones
increase insulin sensitivity in peripheral tissue: increase GLUT express
binds to PPAR-gamma nuclear transcription regulator: regulate release of adipokines from adipose tissue
use as monotherapy in type 2 or combined
TOX: weight gain, edema, hepatotoxicity, HF
Rosigilitazone
Glitazones/thiazolidinediones
increase insulin sensitivity in peripheral tissue: increase GLUT express
binds to PPAR-gamma nuclear transcription regulator: regulate release of adipokines from adipose tissue
use as monotherapy in type 2 or combined
TOX: weight gain, edema, hepatotoxicity, HF
Acarbose
alpha-glucosidase inhibitor: inhibit intestinal brush-boarder alpha-glucosidases, delayed sugar hydrolysis and glucose absorption–>decrease postrandial hyperglycemia
Used as monotherapy in type 2 DM or in combination with above agents
TOX: GI disturbance
miglitol
alpha-glucosidase inhibitor: inhibit intestinal brush-boarder alpha-glucosidases, delayed sugar hydrolysis and glucose absorption–>decrease postrandial hyperglycemia
Used as monotherapy in type 2 DM or in combination with above agents
TOX: GI disturbance
pramlintide
amylin analogs : decrease glucagon
type1 and type2 DM
TOX:hypoglycemia, nausea, diarrhea
exenatide
GLP-1 analogs: increase insulin, decrease glucagon
for type 2
TOX: N/V, pancreatitis
liraglutide
GLP-1(glucagon like peptide)analogs: increase insulin, decrease glucagon
for type 2
TOX: N/V, pancreatitis
linagliptin
DPP-4 inhibitor: increase insulin, decrease glucagon
Type 2 DM
TOX: mild urinary or respiratory infection
saxaliptin
DPP-4 inhibitor: increase insulin, decrease glucagon
Type 2 DM
TOX: mild urinary or respiratory infection
sitagliptin
DPP-4 inhibitor: increase insulin, decrease glucagon
Type 2 DM
TOX: mild urinary or respiratory infection
Propythiouracil
block peroxidase, there by inhibiting organification of iodide and coupling of thyroid hormone synthesis. blocks 5’-deiodinase, increase peripheral conversion of T4 to T3
use in hyperthyoidism
TOX: skin rash, agranulocytosis(rare), aplastic anemia, hepatotoxicity